PTGS2 and cancer: The mechanisms of action that have been documented to date show that PL works by targeting several molecular mechanisms involved in cancer, such as phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), nuclear factor kappa B (NF-κB), and cyclooxygenase-2 (COX-2) [14].